Is USPH a good stock to buy? We came across a bullish thesis on U.S. Physical Therapy, Inc. on Quality At A Fair Price’s Substack. In this article, we will summarize the bulls’ thesis on USPH. U.S. Physical Therapy, Inc.’s share was trading at $75.72 as of April 20th. USPH’s trailing and forward P/E were 53.32 and 27.03, respectively, according to Yahoo Finance.
Photographee.eu/Shutterstock.com
U.S. Physical Therapy (USPH) is a leading operator of outpatient physical and occupational therapy clinics across the United States, focusing on pre- and post-operative care and benefiting from long-term demand driven by aging demographics and increasing rehabilitation needs.
Read More: 15 AI Stocks That Are Quietly Making Investors Rich
Read More: Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential
The company has built a consistent track record over decades, combining steady clinic expansion with a disciplined operating model that supports stable cash flows. It has also maintained a shareholder-friendly approach, paying dividends for nearly 15 years, with a current yield of 2.27%, which stands above its 5-year average yield of 1.82%, implying the stock may be trading at an approximate 17% discount relative to historical valuation norms.
While USPH has historically delivered strong dividend growth, this momentum slowed notably in 2023, with increases falling below 5% and bringing the 3-year dividend growth rate to just above 3%. This deceleration raises some concern about near-term capital return acceleration, particularly for income-focused investors who had grown accustomed to higher growth rates. However, the broader investment case remains supported by the company’s underlying fundamentals, including resilient demand, a fragmented industry structure that allows for continued consolidation, and the potential for margin stability over time.
Despite the recent slowdown in dividend growth, USPH still presents an attractive total return profile, with a projected forward rate of return exceeding 15%. If dividend growth reaccelerates alongside earnings expansion, the current valuation discount could narrow, providing both income and capital appreciation upside, making it a compelling opportunity for long-term investors seeking stable healthcare exposure.
Previously, we covered a bullish thesis on Tenet Healthcare Corporation (THC) by BlackSwanInvestor in December 2024, which highlighted the company’s shift toward higher-margin ambulatory care, strong deleveraging, and significant valuation upside driven by improved cash flow. THC’s stock price has appreciated by approximately 52.15% since our coverage. Quality At A Fair Price shares a similar view but emphasizes on dividend yield-driven valuation and steady outpatient therapy growth.
U.S. Physical Therapy, Inc. is not on our list of the 40 Most Popular Stocks Among Hedge Funds. As per our database, 13 hedge fund portfolios held USPH at the end of the fourth quarter which was 18 in the previous quarter. While we acknowledge the risk and potential of USPH as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than USPH and that has 10,000% upside potential, check out our report about this cheapest AI stock.
Disclosure: None.
